These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3148508)

  • 1. Scheduling-dependent interaction for the combination of cytosine arabinoside and daunorubicin on HL-60 cells.
    Bernabei PA; Rombolà G; Saccardi R; Bezzini R; Santini V; Pifferi C; Gattei V; Ferrini PR
    Haematologica; 1988; 73(6):466-70. PubMed ID: 3148508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probable cures of adult acute leukemia using short term intensive investigational chemotherapy.
    Vaughan WP; Karp JE; Burke PJ
    Nebr Med J; 1984 Aug; 69(8):264-8. PubMed ID: 6483053
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitoxantrone.
    Med Lett Drugs Ther; 1988 Jul; 30(769):67-8. PubMed ID: 3380059
    [No Abstract]   [Full Text] [Related]  

  • 5. Modeling of in vitro drug activity and prediction of clinical outcome in acute myeloid leukemia.
    Quartino A; Karlsson MO; Freijs A; Jonsson N; Nygren P; Kristensen J; Lindhagen E; Larsson R
    J Clin Pharmacol; 2007 Aug; 47(8):1014-21. PubMed ID: 17660484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia.
    Roberts MM; Juttner CA; Blunden RW; Horvath N; To LB; Ho JQ; Dart GW; Kimber RJ
    Med J Aust; 1988 Feb; 148(4):181-3. PubMed ID: 3340044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro short-term sensitivity test for the prediction of response to chemotherapy in acute non-lymphocytic leukemia.
    Saccardi R; Bernabei PA; Bezzini R; Agostino FC; Leoni F; Rossi Ferrini P
    Chemioterapia; 1988 Jun; 7(3):173-8. PubMed ID: 3168072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High-dose treatment].
    Takaku F
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):830-8. PubMed ID: 3872631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
    Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
    J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose cytosine arabinoside and daunomycin as primary therapy for adults with acute nonlymphoblastic leukemia: a pilot study.
    Forman SJ; Nademanee AP; O'Donnell MR; Fahey JL; Snyder DS; Farbstein MJ; Lazar GS; DuBois NJ; Blume KG
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):114-6. PubMed ID: 4012336
    [No Abstract]   [Full Text] [Related]  

  • 12. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
    Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
    Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
    Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
    Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytosine arabinoside in experimental combination therapy.
    Edelstein M; Valeriote F
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):75-83. PubMed ID: 3892705
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combination chemotherapy with cytosine arabinoside and daunomycin in childhood acute leukemia].
    Tsukimoto I; Mimaya J; Toyosaka H; Nagao T; Hanawa Y
    Rinsho Ketsueki; 1973 May; 14(5):596-603. PubMed ID: 4738276
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination amsacrine and high-dose cytosine arabinoside in acute leukemia.
    Arlin ZA
    J Clin Oncol; 1985 Jan; 3(1):128. PubMed ID: 3838101
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy with cytosine arabinoside, daunomycin and vincristine in refractory leukemia of childhood (author's transl)].
    Akatsuka J; Ueda Y; Ohmi K; Shike S; Nishimura K
    Rinsho Ketsueki; 1975 Oct; 16(10):931-5. PubMed ID: 1239527
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, 6-mercaptopurine riboside and prednisolone].
    Hirano M; Morita A; Sako F; Uetani T; Koie K
    Rinsho Ketsueki; 1972 Dec; 13(6):951-7. PubMed ID: 4675066
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral idarubicin in combination with cytosine-arabinoside in previously untreated patients with acute non-lymphocytic leukemia.
    Falkson G; Coccia-Portugal MA; Vorobiof DA; Terblanche AP; Dreyer R
    Am J Clin Oncol; 1986 Aug; 9(4):311-4. PubMed ID: 3463190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose cytosine arabinoside in the consolidation therapy of acute nonlymphocytic leukemia in remission.
    Takaku F; Urabe A; Mizoguchi H; Hoshino S; Toyama K; Tanaka K; Nomura T; Dan K; Fujioka S; Saito T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):55-7. PubMed ID: 3589698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.